Liangji Dynamic
According to the Measures for the Administration
Release time:
2024-01-29
Author:
Source:
According to the Measures for the Administration of Good Manufacturing Practice Certification of Drugs and the Notice on Issuing the Measures for the Administration of Good Manufacturing Practice Certification of Drugs (State Food and Drug Administration [2011] No. 365) issued by the State Food and Drug Administration, after on-site inspection and audit, Guizhou Liangji Pharmaceutical Co., Ltd. complies with the Good Manufacturing Practice of Drugs (revised in 2010) and is now publicly announced. The public notice period is 10 working days, from December 10, 2019 to December 23, 2019.
Catalogue of Drug GMP Certification Review and Publicity of Guizhou Provincial Food and Drug Evaluation and Inspection Center (No. 163)
Related Documents
Related News

